Plunkett Research Online: ImmuPharma

IMMUPHARMA (IMMPF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ImmuPharma PLC is a drug discovery and development company. Its pipeline includes novel peptide-based therapeutics within four therapy areas: Autoimmunity, Anti-Infectives, Metabolism, and Cancer. Its lead drug candidate is Lupuzor, which is a treatment for lupus and life-threatening autoimmune dise.....



ImmuPharma
Ticker: IMMPF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 2071524080
Fax: 44 2071524001
Address: One Bartholomew Close
London, EC1A 7BL United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description
Timothy McCarthy CEO/Chairman of the Board/Director
Timothy Franklin COO/Director
See More
ImmuPharma PLC is a drug discovery and development company. Its pipeline includes novel peptide-based therapeutics within four therapy areas: Autoimmunity, Anti-Infectives, Metabolism, and Cancer. Its lead drug candidate is Lupuzor, which is a treatment for lupus and life-threatening autoimmune dise.....See More See More

Auditor: Nexia Smith & Williamson
Legal Advisor: BDB Pitmans LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (GBP) Bonus (GBP)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: